Sweden's Karo Snaps Up LEO's OTC Derma Brands

Karo Pharma will pay LEO Pharma €90m for a basket of dermatology and anti-hemorrhoid brands to expand its European footprint.

MergerAcquisition
• Source: Shutterstock

Sweden’s Karo Pharma AB is poised to beef up its consumer health portfolio by acquiring a basket of brands from Denmark’s Leo Pharma AS for €90m ($101m). The transaction is expected to close during the first quarter of 2020, subject to regulatory approval.

Karo said the acquisition would strengthen its position in Europe, notably in the DACH region (Germany, Austria and Switzerland), and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

AESGP Annual Meeting: Consumer Health Sector Still Safe Bet For Investors

 
• By 

A healthy diversity of different types of players and plenty of space for scaling up are among the reasons that investors remain interested in the consumer health sector, according to investment bankers speaking at the recent AESGP Annual Meeting.

Germany’s PharmaSGP To Be Taken Private

 
• By 

Consumer health player PharmaSGP will be taken private by its biggest shareholder, FUTRUE.

Alliance Pharma’s New Owners Will Instill ‘More Consumer-Oriented Mindset’

 
• By 

Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.

C&D Taps Hand Sanitizer Category With Touchland

 

Deal totaling as much as $880m extends C&D into additional product category with a brand it says is the fastest growing in the US hand sanitizer category and No. 2 brand in the category overall.

More from Business

People On The Move: Appointments At Klosterfrau, Haleon, Opella

 
• By 

A round-up of the latest consumer health industry appointments: Kloserfrau makes changes to management in Germany; Haleon hires Pakistan head; Opella names Americas leader.

Stada Held Back By Weak Cough & Cold Season

 
• By 

While sales of seasonal products struggled during Q1, Stada pointed to the continuing strength of its underlying Consumer Healthcare portfolio.

US Consumer Health, Beauty Sectors: Expecting Tariff Policy Changes, Buckling Up For The Ride

 

As firms in OTC drug, dietary supplement and personal care/beauty sectors reported results for January-March period after Trump announced reciprocal tariffs, they buckled up for more changes in the president’s thinking likely to affect consumer spending as well as their costs.